Standout Papers

The Functional Assessment of Cancer Therapy scale: development and validation of the general ... 1993 2026 2004 2015 4.6k
  1. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. (1993)
    David Cella, David S. Tulsky et al. Journal of Clinical Oncology
  2. Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer (2007)
    Kathy D. Miller, Molin Wang et al. New England Journal of Medicine
  3. The Patient-Reported Outcomes Measurement Information System (PROMIS) (2007)
    David Cella, Susan Yount et al. Medical Care
  4. Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer (2003)
    Mark G. Kris, Ronald B. Natale et al. JAMA
  5. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes (2007)
    Dennis A. Revicki, Ron D. Hays et al. Journal of Clinical Epidemiology
  6. Item Banks for Measuring Emotional Distress From the Patient-Reported Outcomes Measurement Information System (PROMIS®): Depression, Anxiety, and Anger (2011)
    Paul A. Pilkonis, Seung W. Choi et al. Assessment
  7. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system (1997)
    S B Yellen, David Cella et al. Journal of Pain and Symptom Management
  8. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. (1997)
    Marianne J. Brady, David Cella et al. Journal of Clinical Oncology
  9. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items (2009)
    Ron D. Hays, Jakob Bue Bjørner et al. Quality of Life Research
  10. Measuring spiritual well-being in people with cancer: The functional assessment of chronic illness therapy—spiritual well-being scale (FACIT-Sp) (2002)
    Amy H. Peterman, George Fitchett et al. Annals of Behavioral Medicine
  11. Psychometric Evaluation and Calibration of Health-Related Quality of Life Item Banks (2007)
    Bryce B. Reeve, Ron D. Hays et al. Medical Care
  12. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. (2003)
    Kimberly Webster, David Cella et al. Health and Quality of Life Outcomes
  13. Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition (2000)
    Gregory A. Curt, William Breitbart et al. The Oncologist
  14. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial (2005)
    Stephen K. Tyring, Alice B. Gottlieb et al. The Lancet
  15. Development of a PROMIS item bank to measure pain interference (2010)
    Dagmar Amtmann, Karon F. Cook et al. Pain
  16. Combining Anchor and Distribution-Based Methods to Derive Minimal Clinically Important Differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue Scales (2002)
    David Cella, David T. Eton et al. Journal of Pain and Symptom Management
  17. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer (2007)
    A. Simon Pickard, Maureen P. Neary et al. Health and Quality of Life Outcomes
  18. Fatigue in cancer patients compared with fatigue in the general United States population (2002)
    David Cella, Jin‐Shei Lai et al. Cancer
  19. A case for including spirituality in quality of life measurement in oncology (1999)
    Marianne J. Brady, Amy H. Peterman et al. Psycho-Oncology
  20. Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrument (1995)
    David Cella, Amy E. Bonomi et al. Lung Cancer
  21. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. (1997)
    Nicholas J. Vogelzang, William Breitbart et al. PubMed
  22. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. (1998)
    George D. Demetri, Mark G. Kris et al. Journal of Clinical Oncology
  23. Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial (2011)
    Patrick J. Loehrer, Yang Feng et al. Journal of Clinical Oncology
  24. Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) (2016)
    Jonas A. de Souza, Bonnie J. Yap et al. Cancer
  25. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. (1997)
    David Cella PubMed
  26. A Comprehensive Method for the Translation and Cross-Cultural Validation of Health Status Questionnaires (2005)
    Sonya Eremenco, David Cella et al. Evaluation & the Health Professions
  27. Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients (2011)
    Kathleen J. Yost, David T. Eton et al. Journal of Clinical Epidemiology
  28. Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study (2009)
    Bradley J. Monk, Michael W. Sill et al. Journal of Clinical Oncology
  29. The development of a financial toxicity patient‐reported outcome in cancer: The COST measure (2014)
    Jonas A. de Souza, Bonnie J. Yap et al. Cancer
  30. PROMIS® Adult Health Profiles: Efficient Short-Form Measures of Seven Health Domains (2019)
    David Cella, Seung W. Choi et al. Value in Health
  31. PROMIS®-29 v2.0 profile physical and mental health summary scores (2018)
    Ron D. Hays, Karen L. Spritzer et al. Quality of Life Research
  32. Establishing a common metric for depressive symptoms: Linking the BDI-II, CES-D, and PHQ-9 to PROMIS Depression. (2014)
    Seung W. Choi, Benjamin D. Schalet et al. Psychological Assessment
  33. Clinical validity of PROMIS Depression, Anxiety, and Anger across diverse clinical samples (2016)
    Benjamin D. Schalet, Paul A. Pilkonis et al. Journal of Clinical Epidemiology
  34. PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions (2016)
    Karon F. Cook, Sally E. Jensen et al. Journal of Clinical Epidemiology
  35. Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures (2021)
    Caroline B. Terwee, John Devin Peipert et al. Quality of Life Research

Immediate Impact

8 from Science/Nature 138 standout
Sub-graph 1 of 16

Citing Papers

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
2021 Standout
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
2021 Standout
19 intermediate papers

Works of David Cella being referenced

Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study
2009 Standout
Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
2004
and 5 more

Author Peers

Author Last Decade Papers Cites
David Cella 36142 18003 8579 14947 1.2k 91.6k
Graham A. Colditz 32864 11054 3000 9036 1.4k 162.0k
Neil K. Aaronson 17199 9304 4554 6442 457 45.9k
Stuart Pocock 9393 16133 8313 6721 569 137.2k
Jan P. Vandenbroucke 8818 12248 5045 7200 439 107.2k
Gordon Guyatt 9155 28738 16319 9036 1.3k 166.8k
Henrik Toft Sørensen 8401 9272 2446 6708 1.6k 75.0k
Jonathan J Deeks 7918 11118 2813 5438 346 90.3k
Andrew D Oxman 6183 11315 10554 7316 282 102.0k
Holger J. Schünemann 5335 11004 8513 4545 693 82.6k
M. Hassan Murad 6081 15504 2424 5369 955 98.8k

All Works

Loading papers...

Rankless by CCL
2026